The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43. e69864
Tar DNA binding protein 43 (TDP-43) is the major component of pathological deposits in frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and in amyotrophic lateral sclerosis (ALS). It has been reported that TDP-43 transgenic mouse models expressing human TDP-43 wild-type or ALS-ass...
Gespeichert in:
Veröffentlicht in: | PloS one 2013-07, Vol.8 (7) |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | |
container_title | PloS one |
container_volume | 8 |
creator | Xu, Ya-Fei Prudencio, Mercedes Hubbard, Jaime M Tong, Jimei Whitelaw, Ena C Jansen-West, Karen Stetler, Caroline Cao, Xiangkun Song, John Zhang, Yong-Jie |
description | Tar DNA binding protein 43 (TDP-43) is the major component of pathological deposits in frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and in amyotrophic lateral sclerosis (ALS). It has been reported that TDP-43 transgenic mouse models expressing human TDP-43 wild-type or ALS-associated mutations recapitulate certain ALS and FTLD pathological phenotypes. Of note, expression of human TDP-43 (hTDP-43) reduces the levels of mouse Tdp-43 (mTdp-43). However, it remained unclear whether the mechanisms through which TDP-43 induces ALS or FTLD-like pathologies resulted from a reduction in mTdp-43, an increase in hTDP-43, or a combination of both. In elucidating the role of mTdp-43 and hTDP-43 in hTDP-43 transgenic mice, we observed that reduction of mTdp-43 in non-transgenic mice by intraventricular brain injection of AAV1-shTardbp leads to a dramatic increase in the levels of splicing variants of mouse sortilin 1 and translin. However, the levels of these two abnormal splicing variants are not increased in hTDP-43 transgenic mice despite significant downregulation of mTdp-43 in these mice. Moreover, further downregulation of mTdp-43 in hTDP-43 hemizygous mice, which are asymptomatic, to the levels equivalent to that of mTdp-43 in hTDP-43 homozygous mice does not induce the pathological phenotypes observed in the homozygous mice. Lastly, the number of dendritic spines and the RNA levels of TDP-43 RNA targets critical for synapse formation and function are significantly decreased in symptomatic homozygous mice. Together, our findings indicate that mTdp-43 downregulation does not lead to a loss of function mechanism or account for the pathological phenotypes observed in hTDP-43 homozygous mice because hTDP-43 compensates for the reduction, and associated functions of mTdp-43. Rather, expression of hTDP-43 beyond a certain threshold leads to abnormal metabolism of TDP-43 RNA targets critical for neuronal structure and function, which might be responsible for the ALS or FTLD-like pathologies observed in homozygous hTDP-43 transgenic mice. |
doi_str_mv | 10.1371/journal.pone.0069864 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1430861274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1430861274</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_14308612743</originalsourceid><addsrcrecordid>eNqVjstOwzAURC0kpJbHH7C4SzYJdpy66RJRUFkgZeF9ZSW3SSr32vghxIJ_JwV-gM2MNJozGsbuBC-FXIuHo8uBjC29Iyw5V5tG1RdsKTayKlTF5YJdxXjkfCUbpZbsS48IrUmjs26YOmOhHZFc-vQYwR1gl0-GQG_bopagg6E4IE0dvLkccdYebYTHgPBKPXqchdKZ27oPCjhka9Lk6Jz8Err381IJ-HPshl0ejI14--fX7P7lWT_tCh_ce8aY9qcpdmitIZzxvaglb5So1rX8R_Ub3q1YQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1430861274</pqid></control><display><type>article</type><title>The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43. e69864</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Xu, Ya-Fei ; Prudencio, Mercedes ; Hubbard, Jaime M ; Tong, Jimei ; Whitelaw, Ena C ; Jansen-West, Karen ; Stetler, Caroline ; Cao, Xiangkun ; Song, John ; Zhang, Yong-Jie</creator><creatorcontrib>Xu, Ya-Fei ; Prudencio, Mercedes ; Hubbard, Jaime M ; Tong, Jimei ; Whitelaw, Ena C ; Jansen-West, Karen ; Stetler, Caroline ; Cao, Xiangkun ; Song, John ; Zhang, Yong-Jie</creatorcontrib><description>Tar DNA binding protein 43 (TDP-43) is the major component of pathological deposits in frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and in amyotrophic lateral sclerosis (ALS). It has been reported that TDP-43 transgenic mouse models expressing human TDP-43 wild-type or ALS-associated mutations recapitulate certain ALS and FTLD pathological phenotypes. Of note, expression of human TDP-43 (hTDP-43) reduces the levels of mouse Tdp-43 (mTdp-43). However, it remained unclear whether the mechanisms through which TDP-43 induces ALS or FTLD-like pathologies resulted from a reduction in mTdp-43, an increase in hTDP-43, or a combination of both. In elucidating the role of mTdp-43 and hTDP-43 in hTDP-43 transgenic mice, we observed that reduction of mTdp-43 in non-transgenic mice by intraventricular brain injection of AAV1-shTardbp leads to a dramatic increase in the levels of splicing variants of mouse sortilin 1 and translin. However, the levels of these two abnormal splicing variants are not increased in hTDP-43 transgenic mice despite significant downregulation of mTdp-43 in these mice. Moreover, further downregulation of mTdp-43 in hTDP-43 hemizygous mice, which are asymptomatic, to the levels equivalent to that of mTdp-43 in hTDP-43 homozygous mice does not induce the pathological phenotypes observed in the homozygous mice. Lastly, the number of dendritic spines and the RNA levels of TDP-43 RNA targets critical for synapse formation and function are significantly decreased in symptomatic homozygous mice. Together, our findings indicate that mTdp-43 downregulation does not lead to a loss of function mechanism or account for the pathological phenotypes observed in hTDP-43 homozygous mice because hTDP-43 compensates for the reduction, and associated functions of mTdp-43. Rather, expression of hTDP-43 beyond a certain threshold leads to abnormal metabolism of TDP-43 RNA targets critical for neuronal structure and function, which might be responsible for the ALS or FTLD-like pathologies observed in homozygous hTDP-43 transgenic mice.</description><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0069864</identifier><language>eng</language><subject>Amyotrophic lateral sclerosis</subject><ispartof>PloS one, 2013-07, Vol.8 (7)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,866,27933,27934</link.rule.ids></links><search><creatorcontrib>Xu, Ya-Fei</creatorcontrib><creatorcontrib>Prudencio, Mercedes</creatorcontrib><creatorcontrib>Hubbard, Jaime M</creatorcontrib><creatorcontrib>Tong, Jimei</creatorcontrib><creatorcontrib>Whitelaw, Ena C</creatorcontrib><creatorcontrib>Jansen-West, Karen</creatorcontrib><creatorcontrib>Stetler, Caroline</creatorcontrib><creatorcontrib>Cao, Xiangkun</creatorcontrib><creatorcontrib>Song, John</creatorcontrib><creatorcontrib>Zhang, Yong-Jie</creatorcontrib><title>The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43. e69864</title><title>PloS one</title><description>Tar DNA binding protein 43 (TDP-43) is the major component of pathological deposits in frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and in amyotrophic lateral sclerosis (ALS). It has been reported that TDP-43 transgenic mouse models expressing human TDP-43 wild-type or ALS-associated mutations recapitulate certain ALS and FTLD pathological phenotypes. Of note, expression of human TDP-43 (hTDP-43) reduces the levels of mouse Tdp-43 (mTdp-43). However, it remained unclear whether the mechanisms through which TDP-43 induces ALS or FTLD-like pathologies resulted from a reduction in mTdp-43, an increase in hTDP-43, or a combination of both. In elucidating the role of mTdp-43 and hTDP-43 in hTDP-43 transgenic mice, we observed that reduction of mTdp-43 in non-transgenic mice by intraventricular brain injection of AAV1-shTardbp leads to a dramatic increase in the levels of splicing variants of mouse sortilin 1 and translin. However, the levels of these two abnormal splicing variants are not increased in hTDP-43 transgenic mice despite significant downregulation of mTdp-43 in these mice. Moreover, further downregulation of mTdp-43 in hTDP-43 hemizygous mice, which are asymptomatic, to the levels equivalent to that of mTdp-43 in hTDP-43 homozygous mice does not induce the pathological phenotypes observed in the homozygous mice. Lastly, the number of dendritic spines and the RNA levels of TDP-43 RNA targets critical for synapse formation and function are significantly decreased in symptomatic homozygous mice. Together, our findings indicate that mTdp-43 downregulation does not lead to a loss of function mechanism or account for the pathological phenotypes observed in hTDP-43 homozygous mice because hTDP-43 compensates for the reduction, and associated functions of mTdp-43. Rather, expression of hTDP-43 beyond a certain threshold leads to abnormal metabolism of TDP-43 RNA targets critical for neuronal structure and function, which might be responsible for the ALS or FTLD-like pathologies observed in homozygous hTDP-43 transgenic mice.</description><subject>Amyotrophic lateral sclerosis</subject><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqVjstOwzAURC0kpJbHH7C4SzYJdpy66RJRUFkgZeF9ZSW3SSr32vghxIJ_JwV-gM2MNJozGsbuBC-FXIuHo8uBjC29Iyw5V5tG1RdsKTayKlTF5YJdxXjkfCUbpZbsS48IrUmjs26YOmOhHZFc-vQYwR1gl0-GQG_bopagg6E4IE0dvLkccdYebYTHgPBKPXqchdKZ27oPCjhka9Lk6Jz8Err381IJ-HPshl0ejI14--fX7P7lWT_tCh_ce8aY9qcpdmitIZzxvaglb5So1rX8R_Ub3q1YQw</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Xu, Ya-Fei</creator><creator>Prudencio, Mercedes</creator><creator>Hubbard, Jaime M</creator><creator>Tong, Jimei</creator><creator>Whitelaw, Ena C</creator><creator>Jansen-West, Karen</creator><creator>Stetler, Caroline</creator><creator>Cao, Xiangkun</creator><creator>Song, John</creator><creator>Zhang, Yong-Jie</creator><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20130701</creationdate><title>The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43. e69864</title><author>Xu, Ya-Fei ; Prudencio, Mercedes ; Hubbard, Jaime M ; Tong, Jimei ; Whitelaw, Ena C ; Jansen-West, Karen ; Stetler, Caroline ; Cao, Xiangkun ; Song, John ; Zhang, Yong-Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_14308612743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Amyotrophic lateral sclerosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Ya-Fei</creatorcontrib><creatorcontrib>Prudencio, Mercedes</creatorcontrib><creatorcontrib>Hubbard, Jaime M</creatorcontrib><creatorcontrib>Tong, Jimei</creatorcontrib><creatorcontrib>Whitelaw, Ena C</creatorcontrib><creatorcontrib>Jansen-West, Karen</creatorcontrib><creatorcontrib>Stetler, Caroline</creatorcontrib><creatorcontrib>Cao, Xiangkun</creatorcontrib><creatorcontrib>Song, John</creatorcontrib><creatorcontrib>Zhang, Yong-Jie</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Ya-Fei</au><au>Prudencio, Mercedes</au><au>Hubbard, Jaime M</au><au>Tong, Jimei</au><au>Whitelaw, Ena C</au><au>Jansen-West, Karen</au><au>Stetler, Caroline</au><au>Cao, Xiangkun</au><au>Song, John</au><au>Zhang, Yong-Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43. e69864</atitle><jtitle>PloS one</jtitle><date>2013-07-01</date><risdate>2013</risdate><volume>8</volume><issue>7</issue><eissn>1932-6203</eissn><abstract>Tar DNA binding protein 43 (TDP-43) is the major component of pathological deposits in frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and in amyotrophic lateral sclerosis (ALS). It has been reported that TDP-43 transgenic mouse models expressing human TDP-43 wild-type or ALS-associated mutations recapitulate certain ALS and FTLD pathological phenotypes. Of note, expression of human TDP-43 (hTDP-43) reduces the levels of mouse Tdp-43 (mTdp-43). However, it remained unclear whether the mechanisms through which TDP-43 induces ALS or FTLD-like pathologies resulted from a reduction in mTdp-43, an increase in hTDP-43, or a combination of both. In elucidating the role of mTdp-43 and hTDP-43 in hTDP-43 transgenic mice, we observed that reduction of mTdp-43 in non-transgenic mice by intraventricular brain injection of AAV1-shTardbp leads to a dramatic increase in the levels of splicing variants of mouse sortilin 1 and translin. However, the levels of these two abnormal splicing variants are not increased in hTDP-43 transgenic mice despite significant downregulation of mTdp-43 in these mice. Moreover, further downregulation of mTdp-43 in hTDP-43 hemizygous mice, which are asymptomatic, to the levels equivalent to that of mTdp-43 in hTDP-43 homozygous mice does not induce the pathological phenotypes observed in the homozygous mice. Lastly, the number of dendritic spines and the RNA levels of TDP-43 RNA targets critical for synapse formation and function are significantly decreased in symptomatic homozygous mice. Together, our findings indicate that mTdp-43 downregulation does not lead to a loss of function mechanism or account for the pathological phenotypes observed in hTDP-43 homozygous mice because hTDP-43 compensates for the reduction, and associated functions of mTdp-43. Rather, expression of hTDP-43 beyond a certain threshold leads to abnormal metabolism of TDP-43 RNA targets critical for neuronal structure and function, which might be responsible for the ALS or FTLD-like pathologies observed in homozygous hTDP-43 transgenic mice.</abstract><doi>10.1371/journal.pone.0069864</doi></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1932-6203 |
ispartof | PloS one, 2013-07, Vol.8 (7) |
issn | 1932-6203 |
language | eng |
recordid | cdi_proquest_miscellaneous_1430861274 |
source | Public Library of Science (PLoS) Journals Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Amyotrophic lateral sclerosis |
title | The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43. e69864 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T07%3A35%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Pathological%20Phenotypes%20of%20Human%20TDP-43%20Transgenic%20Mouse%20Models%20Are%20Independent%20of%20Downregulation%20of%20Mouse%20Tdp-43.%20e69864&rft.jtitle=PloS%20one&rft.au=Xu,%20Ya-Fei&rft.date=2013-07-01&rft.volume=8&rft.issue=7&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0069864&rft_dat=%3Cproquest%3E1430861274%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1430861274&rft_id=info:pmid/&rfr_iscdi=true |